Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments.
Lupia T, De Benedetto I, Bosio R, Shbaklo N, De Rosa FG, Corcione S.
Life (Basel). 2023 Apr 6;13(4):959. doi: 10.3390/life13040959.
PMID:37109488
Cardiac device-related infective endocarditis in the Czech Republic: Prospective data from the ESC EORP EURO-ENDO registry.
Latal J, Pazdernik M, Holicka M, Pelouch R, Widimsky J, Pudich J, Vancata R, Siranec M, Blechova K, Butta T, Mikulcova M, Mikulica M, Wohlfahrt P, Hutyra M, Precek J.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 May;166(2):168-172. doi: 10.5507/bp.2021.013. Epub 2021 Feb 22.
PMID:33724263
Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature.
Sanghavi R, Ravikumar N, Sarodaya V, Haq M, Sherif M, Harky A.
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).